Low levels of vitamin D, UV radiation, and sun exposure are well established risk factors for MS. However, it is not yet clear whether supplementation of these factors could prevent…read more
It is known that people develop MS due to a combination of risk genes and environmental factors. One way that environmental factors can interact with genes is through methylation.read more
Researchers from the University of Adelaide have identified a key protein on the surface of cells that controls the immune attack in MS.read more
The journey to deliver a new (and first-ever) treatment for secondary progressive MS has been bolstered by a $1.2 million grant to Dr Anne La Flamme.read more
The New Zealand Multiple Sclerosis Research Trust (“NZMSRT”) today announces that Sir Leonard Willson is to take up the position of Patron of the Trust.read more
MS Research Australia recently supported the 2015 Myelin Meeting, a satellite meeting of the biennial conference of the International Society of Neurochemistry held in late September in Cairns.read more
There are challenges involved in accurately measuring the gradual accumulation of disability in MS.read more
The International Progressive MS Alliance is a growing global initiative to end progressive MS. MS Research Australia, along with MS organisations from around the world, have joined the Alliance, and…read more
The bacteria present in a person’s intestines perform a number of vital functions including providing nutrients, producing vitamins and aiding in the digestion of food.read more
Last week saw the biggest event on the international MS research calendar, the 2015 European Committee for Treatment and Research in MS (ECTRIMS) conference held in Barcelona, Spain.read more
MS results from the loss of myelin, the insulating coating of nerve fibres, in the brain and spinal cord. Lost myelin can be replaced and repaired naturally by stem cells…read more
Genentech, a biotechnology company owned by Roche Pharmaceuticals, has announced promising results from a phase III clinical trial of experimental therapy ocrelizumab in people with primary progressive MS.read more
Progressive multifocal leukoencephalopathy (PML) is a potentially fatal brain infection that is caused by activation of the JC virus.read more
Research has shown that future declines in thinking and memory skills may be avoided by taking part in challenging and mentally stimulating activities.read more
The International MS Genetics Consortium, which includes Australian and New Zealand researchers via the MS Research Australia-supported ANZgene collaboration, has revealed further details of how genes interact to determine an…read more
There is a great deal of interest in the role that nutrition and diet may play in the development and also the management of MS and here we have summarised…read more
Melatonin is a hormone produced in the body which is involved in setting our natural circadian rhythm (sleep-wake cycle).read more
A recent study from Polish researchers has explored the association between how people feel about their MS, their self-esteem, and their ability to self-manage their illness.read more
Since 2008 people with MS have been able to make a very special gift to MS research by donating their precious brain and spinal cord tissue to research via the…read more
Smoking is a well-established risk factor for the development of MS, but the effects of smoking on disease course after diagnosis of MS have been less clear.read more
